Dr James Heward

Postdoctoral Researcher
Research Focus

My research within the Fitzgibbon lab focuses on characterising epigenetic therapies for the “epigenetically addicted” germinal centre lymphomas, whilst my previous work has included working at an epigenetic focused BioTech company (Chroma Therapeutics Ltd) and characterising long non-coding RNAs that regulate the innate immune response during my PhD (University of Bath).

Professor Jude Fitzgibbon
Upcoming Events
  1. 2020 Circulating Cancer Biomarker Symposium

    May 4 @ 9:00 am - 5:30 pm
  2. The London Pancreas Workshop 2020

    September 11 @ 9:30 am - 4:30 pm
© 2013 ~ 2020 Cancer Research UK Barts Centre